miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer
- PMID: 21444677
- DOI: 10.1158/0008-5472.CAN-10-2435
miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer
Abstract
The microRNA miR-125b is dysregulated in various human cancers but its underlying mechanisms of action are poorly understood. Here, we report that miR-125b is downregulated in invasive breast cancers where it predicts poor patient survival. Hypermethylation of the miR-125b promoter partially accounted for reduction of miR-125b expression in human breast cancer. Ectopic restoration of miR-125b expression in breast cancer cells suppressed proliferation, induced G(1) cell-cycle arrest in vitro, and inhibited tumorigenesis in vivo. We identified the ETS1 gene as a novel direct target of miR-125b. siRNA-mediated ETS1 knockdown phenocopied the effect of miR-125b in breast cell lines and ETS1 overexpression in invasive breast cancer tissues also correlated with poor patient prognosis. Taken together, our findings point to an important role for miR-125b in the molecular etiology of invasive breast cancer, and they suggest miR-125b as a potential theranostic tool in this disease.
©2011 AACR
Similar articles
-
A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells.Mol Cancer Res. 2009 Oct;7(10):1635-44. doi: 10.1158/1541-7786.MCR-09-0043. Epub 2009 Oct 13. Mol Cancer Res. 2009. PMID: 19825990
-
miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):31-8. doi: 10.1016/j.bbrc.2011.10.117. Epub 2011 Nov 10. Biochem Biophys Res Commun. 2011. PMID: 22093834
-
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8. Oncogene. 2011. PMID: 21057539
-
The expression and regulation of microRNA-125b in cancers.Acta Biochim Biophys Sin (Shanghai). 2013 Oct;45(10):803-5. doi: 10.1093/abbs/gmt073. Epub 2013 Jun 25. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23800395 Review.
-
The oncogenic role of miR-155 in breast cancer.Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1236-43. doi: 10.1158/1055-9965.EPI-12-0173. Epub 2012 Jun 26. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22736789 Review.
Cited by
-
MiR-338-5p, a novel metastasis-related miRNA, inhibits triple-negative breast cancer progression by targeting the ETS1/NOTCH1 axis.Heliyon. 2024 Jul 20;10(15):e34949. doi: 10.1016/j.heliyon.2024.e34949. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39157351 Free PMC article.
-
MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion.Am J Transl Res. 2024 Jul 15;16(7):3366-3375. doi: 10.62347/QWGS2351. eCollection 2024. Am J Transl Res. 2024. PMID: 39114709 Free PMC article.
-
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.Cancers (Basel). 2024 Mar 12;16(6):1126. doi: 10.3390/cancers16061126. Cancers (Basel). 2024. PMID: 38539461 Free PMC article. Review.
-
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.Noncoding RNA. 2024 Feb 21;10(2):16. doi: 10.3390/ncrna10020016. Noncoding RNA. 2024. PMID: 38525735 Free PMC article. Review.
-
Clinical importance of serum miRNA levels in breast cancer patients.Discov Oncol. 2024 Jan 27;15(1):19. doi: 10.1007/s12672-024-00871-y. Discov Oncol. 2024. PMID: 38280134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous